Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy
Clinical trial NCT07197112 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07197112
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-01
- Primary completion
- 2027-02-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.